| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
75,896 |
61,181 |
$13.00M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,691 |
1,493 |
$311K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,032 |
11,304 |
$251K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,858 |
15,749 |
$213K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
7,473 |
6,968 |
$192K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
759 |
630 |
$126K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,515 |
1,432 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,339 |
38,087 |
$70K |
| 90700 |
|
5,050 |
4,903 |
$42K |
| 90670 |
|
3,428 |
3,347 |
$37K |
| 90713 |
|
3,562 |
3,474 |
$29K |
| 90648 |
|
3,740 |
3,647 |
$29K |
| 90461 |
|
606 |
573 |
$19K |
| 90680 |
|
2,420 |
2,371 |
$19K |
| 90686 |
|
1,713 |
1,648 |
$15K |
| 90744 |
|
1,808 |
1,782 |
$14K |
| 90633 |
|
1,769 |
1,741 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
520 |
500 |
$13K |
| 90707 |
|
1,546 |
1,516 |
$13K |
| 87807 |
|
1,243 |
1,158 |
$13K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,424 |
4,297 |
$12K |
| 90716 |
|
1,513 |
1,484 |
$12K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,392 |
4,253 |
$7K |
| 90671 |
|
345 |
337 |
$5K |
| 90651 |
|
615 |
593 |
$5K |
| 36416 |
|
1,568 |
1,485 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,436 |
2,366 |
$3K |
| 90685 |
|
292 |
289 |
$2K |
| 90688 |
|
199 |
196 |
$2K |
| 99460 |
|
33 |
25 |
$1K |
| 90687 |
|
187 |
173 |
$1K |
| 81003 |
|
339 |
314 |
$978.66 |
| 90661 |
|
157 |
143 |
$888.00 |
| 90619 |
|
111 |
111 |
$875.79 |
| 90734 |
|
86 |
86 |
$691.79 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
27 |
12 |
$644.49 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,076 |
3,699 |
$611.42 |
| 90715 |
|
50 |
50 |
$395.79 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,420 |
1,300 |
$307.16 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
763 |
743 |
$166.24 |
| 99173 |
|
4,410 |
4,249 |
$163.48 |
| 86308 |
|
28 |
28 |
$162.00 |
| 92551 |
|
3,617 |
3,483 |
$150.00 |
| 90621 |
|
16 |
15 |
$120.00 |
| 85018 |
|
14 |
14 |
$42.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
75 |
68 |
$18.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,035 |
1,014 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
518 |
482 |
$0.00 |
| 96127 |
|
1,836 |
1,763 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
163 |
139 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
233 |
200 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
586 |
549 |
$0.00 |